Targeting IL-17A: A Winner in PsA (CME/CE)

(MedPage Today) -- Ixekizumab was effective in patients who had failed TNF inhibitors
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news
More News: Dermatology | Skin